Compare
Amphstar Pharmaceuticals vs Johnson & Johnson (AMPH vs JNJ)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Amphstar Pharmaceuticals (AMPH) returned +12.6% and Johnson & Johnson (JNJ) +48.5%; so far this year the figures are +6.4% and +33.5%.
Johnson & Johnson is the larger company by market value, about 545.0 times the size of Amphstar Pharmaceuticals.
On trailing earnings, AMPH trades at 13.0 times and JNJ at 41.9 times.
Revenue grew +3.1% at AMPH and +7.8% at JNJ over the last year.
AMPH pays no dividend. JNJ yields 1.91%.
Data as of the latest close. Not investment advice.
Relative performance
| AMPH | JNJ | |
|---|---|---|
| Price | $28.49 | $276.22 |
| 1-day | +3.00% | +1.43% |
| YTD | +6.39% | +33.47% |
| 1 year | +12.56% | +48.51% |
| 3 years | -37.30% | +85.77% |
| Market cap | $1.2B | $665.0B |
| P/E | 13.0 | 41.9 |
| P/S | 1.63 | 6.69 |
| P/B | 1.49 | 8.16 |
| Revenue growth | +3.10% | +7.80% |
| EPS growth | -3.10% | -36.40% |
| Gross margin % | 46.8 | 67.6 |
| Net margin % | 13.3 | 16.2 |
| ROE % | 12.1 | 19.7 |
| Debt / equity | 0.75 | 0.55 |
| FCF yield % | 11.4 | 3.1 |
| Dividend yield % | — | 1.91 |
| Beta | 0.55 | -0.09 |
| RSI (14) | 66.7 | 59.4 |
| Technical rating |